Medical Legal

An interesting False Claims Act issue cropped up in a recent $8 million settlement involving U.K.-based medical device…

Pharmaceutical manufacturers routinely offer copayment coupons to reduce or eliminate the cost of patients'…

A New York federal judge recently dismissed two separate cases brought by Fox Rx Inc.--one against Omnicare, the other…

A whistleblower’s False Claims Act (FCA) suit in the Eastern District of California has caught the attention of the…

The U.S. Court of Appeals for the Eighth Circuit rejected a whistleblower suit against Stryker Corp. and other pain pump…

We outlined a special fraud alert that targeted the relationship between blood-testing laboratories and physicians. In…

Many physicians and other healthcare providers refer a high volume of patient specimens to third party clinical…

As reported by the law firm Husch Blackwell, a recent D.C. Circuit court decision reaffirms that the attorney-client privilege…

Since 2006, Celgene Corporation has earned $20.9 billion from the sales of two of its drugs—Thalomid and Revlimid. The drugs are…

Celgene's successful cancer drugs Thalomid and Revlimid are at the center of an antitrust action. On April 3rd, Mylan…